Satellos Bioscience MSLE
NASDAQ MSLE
$6.63 -0.07 (-1.12%)
As of: Oct 22, 2026 · 3:53 PM EDT

Satellos Bioscience (MSLE) Change in Account Payables (2025 - 2026)

Updated

Satellos Bioscience (MSLE) posted Change in Account Payables of $501,000 for the year ended Dec 31, 2025, down 50.5% from $1.01 million a year earlier.

Analysis

Satellos Bioscience (MSLE) Change in Account Payables (2025 - 2026) Analysis & Trends

  • Business Quant data shows MSLE's Change in Account Payables at $1.01 million in the year ended Dec 31, 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn -
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn -
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn -
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn -70.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 18.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Satellos Bioscience 96.70 Mn -111.44 Mn - 1.33 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.33 Mn
Mar 31, 2026 423,000.00
Jun 30, 2025 70,000.00
Mar 31, 2025 -886,000.00
API Access

Satellos Bioscience Change in Account Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-account-payables&ticker=MSLE&period=max&api_key=YOUR_API_KEY